Our data thus suggest that Slc11a2 knockdown in microglia during AD progression leads to decreased expression of ‘protective’ DAM-like markers associated with limiting cellular damage, and instead an exacerbation of deleterious changes observed in aged and AD-associated microglia. The gene discussed is SLC11A2; the disease is Alzheimer disease.